Joshua Michael Stern



Joshua Michael Stern

47 Stoneyside Drive

Larchmont NY 10538

Email: jstern@

Contact: (917)-273-5272

Education:

• University of Pennsylvania, Philadelphia, PA

Bachelor of Arts, 1997

• Cornell University Weill Medical College, New York, NY

Doctor of Medicine with Honors in Research, May 2003

Post-Graduate Training:

• The Mount Sinai Medical Center, New York, NY

General Surgery Internship, 2003

• The University of Texas, Southwestern Medical Center, Dallas, TX

Urology Resident, 2008

• The University of Pennsylvania, Philadelphia, PA

Minimally Invasive Robotic Oncology Fellowship, 2009

Professional Employment and Hospital Appointments:

• Winchester Hospital, Teaching Affiliate to Tufts Medical School

Winchester, Ma: Clinical Assistant Professor of Urology Tufts Medical Center, 2009-2012

• Montefiore Medical Center, Albert Einstein School of Medicine, Bronx, NY: Assistant professor of Urology, Director of Ablative Surgery, 2012-present

Board Certification:

• Urology: 2011

Professional Society Membership:

• American Urologic Association

• American Society for Nephrology

• American Board of Urology

Grants:

▪ American Society of Nephrology Career Development Grant: “Carl W. Gottschalk Research Scholar Grant” 2016-2018

▪ -Is there a Gut Microbiome Signature in Kidney Stone Patients”

Awards and Honors:

• Primary Investigator Protocol #sprix01: “Evaluating post operative pain management efficacy of intra nasal ketorolac in ambulatory urology surgery: A randomized, double blind, placebo controlled study”, 2012-2014

• Outstanding educator award, 2010 Tufts Medical School

• Reviewer Journal of Urology, Journal of Endourology and Urology, 2009-Present

• Member National Young Urologists Committee for the AUA, 2010-2014

• Gerald Murphy AUA scholar, 2006, 2007.

• Nucryst Pharmaceuticals: Nanoparticle investigative grant, 2005-2007

• Doctorate of Medicine degree with honors in research, 2003

• The E. Darracott Vaughan Award for Excellence in Urology, 2003

• “Louis Gibofsky Memorial Award” for the best thesis in nephrology, transplant or immunology, 2003

• Molecular Biology Research Fellowship, 2001-2002

• American Federation for Aging Research (AFAR) Fellowship, Summer 1999

Educational Activity:

• Medical Student Clerkship Director for Urology at Albert Einstein Hospital, 2013-present

• Mentored 1st year medical students “Summer Project” in Urology, Summer 2013-2015

• Surgical Interest Group Mentor, 2013-2015

National and Regional Talks:

• “The Gut Microbiome and Kidney stone: can there be a link”. Weil Cornell Medical Center, Department of Urology Grand Rounds, 2015

• “Metabolic Syndrome and the Development of Kidney Stones” Westchester Medical Center, Department of Urology Grand Rounds, 2015

• “Laser Activated  Nanoshell Ablation of Prostate Cancer: A pilot study in Humans”. Engineering Society for the American Urologic Association, 2013

• “Robotic technique and Technology Highlights from the 2010 Annual Meeting”. New England Section American Urological Association Annual Meeting, Providence RI 2010.

Publications:

Journal articles and chapters

1. Hochberg, D., Johnson, C.W., Chen, J., Cohen, D., Stern, J., Vaughan, E.D. JR., Poppas, D.P., Felsen, D. Interstitial Fibrosis of Unilateral Ureteral Obstruction in Exacerbated in Kidneys of Mice Lacking the Gene for Inducible Nitric Oxide Synthetase. Laboratory Investigation 80: 1721, 2000.

2. Miyajima, A., Chen, J., Lawrence, C., Ledbetter, S., Soslow, R.A., Stern, J., Jha, S., Pigato, J., Lemer, M.L., Poppas, D.P., Vaughan, E.D. JR, Felsen, D. Antibody to transforming growth factor beta ameliorates tubular apotosis in unilateral ureteral obstruction. Kidney International 58: 2301-2313, 2000.

3. Stern JM, Chen J, Silver R, Poppas DP, Vaughan ED. JR, Felsen, D. Effect of UUO on D1AR expression reveals a link between Dopamine, Transforming Growth Factor-β and Nitric Oxide. American Journal of Physiology: Renal Physiol. 2004 Mar; 286(3) F509-15.

4. Stern JM, Chen J, Peters SB, Stahl PJ, El-Chaar M, Feslen D, Poppas DP. Testosterone treatment of human foreskin in a novel transplant model. Urology. 2004 May;63 (5):999-1003.

5.Ito K, Chen, J, El Chaar M, Stern JM, Seshan SV, Khodadadioan JJ, Richardson I, Hyman MJ, Vaughan, ED, Poppas DP, Felsen D. Renal Damage Progresses Despite Improvement of Renal Function After Relief of Unilateral Ureteral Obstruction in Adult Rats. Am J Physiol Renal Physiol. 2004 Dec;287(6):F1283-93.

6. Stern JM, KY A, Steinhagen R. Metastaic Cutaneous Crohns Disease: A case of penile involvement. Surgical Rounds. 2005, September: 425

7. Stern JM, Park S., Anderson JK., Lotan Y, Cadeddu J. NADH Staining Immediately Following Radiofrequency Ablation of Renal Tumors: Is a Positive Stain Synonymous With Ablative Failure? J urol. 176; 1969-1972. Nov, 2006

8. Stern JM, Lotan Y. Imaging in Hematuria: A Review. Contemporary Urology, July 2006.

9. Cohen, MS., Stern JM., Libertino J., Summerhayes I. In vitro Analysis of a Silver Nanocrystalline Surgical Mesh. Surg Infect. 2007 Jun;8(3):397-403.

10. Stern JM., Svatek R., Park S., Lotan Y., Sagalowsky AI., Cadeddu JA. Intermediate Follow-Up Comparison Between Partial Nephrectomy And Radio Frequency Ablation In T1a Renal Tumors. BJU Int. 2007 Aug;100(2):287-90.

11. Stern JM., Park S., Anderson JK., Landman J., Pearle M., Cadeddu JA. Functional Assessment of Crossing Vessels as the Etiology of Uretero Pelvic Junction Obstruction. Urology. 2007 Jun; 69(6):1022-4

12. Stern JM, Yiee J, Park, S. Safety and Efficacy of Ureteral Access Sheaths. J Endo, 21 (2); 119-123. Feb 2007.

13. Stern JM, Zeltser I., Pearle P. Percutaneous Renal Access: A Review of Simulator Training. J Endo, 21(3); 270-273, March 2007.

14. Stern JM, Stanfield J., Lotan Y., Hsieh JT., Cadeddu JA. The efficacy of Laser activated Gold Nanoshells to ablate prostate cancer cells in vitro. J Endourol. 2007 Aug;21(8):939-43

15. Stern JM., Zeltser IS., Lotan Y., Cadeddu JA. Laparoscopic Renal Cyst Decortication. Esential Urologic Laparoscopy. 2007.

16. Stern JM., Yiee J., Park S., Is Routine Ureteral Access Sheath Use Warranted? Contemporary Urology; Jan2007, Vol. 19 Issue 1, p14-18.

17. Raman, JD., Bensalah K., Bagrodia A., Stern JM., Cadeddu JA. Laboratory and Clinical Development of Single Keyhole Umbilical Nephrectomy. Urology 2007 Dec; 70(6):1039-42.

18. Margulis V., Stern JM., Sagalowsky AI., Lotan Y. Radical Cystectomy for Transitional Cell Carcinoma of the Bladder: What Percentage of Patients Qualify for Bladder Preservation Protocols? Curr Urol 2007;1:24-27

19. Lucas S., Stern JM., Raj GV. Renal Function alteration after surgical treatment for clinical T1a renal masses. J Urol. 2008 Jan;179(1):75-9

20. Stern JM, Cadeddu JA. Emerging use of Nanoparticles for the Therapeutic Ablation of Urologic Malignancies. Urol Oncol. 2008 Jan-Feb;26(1):93-6

21. Stern JM, Stanfield J., Hsieh Jer-Tosng., Kabbani W., Cadeddu JA. Selective Prostate Cancer Thermal Ablation with Laser Activated Gold Nanoshells. J Urol 2008 Feb;179(2):748-53.

22. Boucher W., Stern JM., Cohen, MS., Theoharides, T. Intravesical Nanocrystalline Silver Reduces Experimental Bladder Inflammation. Accepted JU, 2008.

23. Stern JM., Merritt M., Cadeddu JA. Magnetic Resonance Spectroscopy Predicts the Histologic Assessment of Radiofrequency Ablated Renal Tissue. Accepted, European Urology, 2008.

24. Raman, J., Stern, JM, Kabbani, W., Cadeddu, JA. Absence Of Viable Renal Carcinoma in Biopsies Performed Greater than 1 Year Following Radiofrequency Ablation Confirms Reliability of Axial Imaging. Accepted JU, 2008.

25. Bensalah K., Tuncel A., Hanson W., Stern JM., Han B., Cadeddu JA. Measurement of Quantum Dot Fluoresncence Emission Can Accurately Monitor a Thermal Ablation Zone in an In Vitro Setting. Submitted International Hyperthermia, 2008.

26. Lucas SM., Nuss G., Stern JM., Lotan, Y., Cadeddu JA., Sagalowsky AI,. Raj GV.

The SCORED value is associated with a higher risk for having or developing chronic kidney disease in patients treated for small unilateral renal masses. Accepted Cancer 2008.

27. Cost N., Stern JM., Baker L., Wilcox D. A Comparison of Laparoscopic Dismembered Pyeloplasty and Laparoscopic Vascular Hitch Pyeloplasty, Submitted JU 2008.

28. Gupta A., Raman JD., Stern JM., Leveillee RL., et al. General Anesthesia and Contrast Enhanced Computed Tomography Optimize Renal Radiofrequency Ablation. Accepted Journal of Endourology 2009

29. Steinberg PL., Wason S., Stern JM., Deters L., Seigne MB. YouTube as a Source of Prostate Cancer Information. Urology. 2010 Mar;75(3):619-22

30. Stern JM., Gupta A., Raman JD., Cost N., Lucas S., Raj GV., Cadeddu JA. “Radiofrequency Ablation of Small Renal Cortical Tumors in Healthy Adults: Renal Function Preservation and Intermediate Oncologic Outcome”. BJU Int. 2009 Sep;104(6):786-9

31. Han B, Hanson WL, Bensalah K, Tuncel A, Stern JM, Cadeddu JA. “Development of quantum dot-mediated fluorescence thermometry for thermal therapies”. Ann Biomed Engineering Jun, 2009 37(6)1230-9

32. Mendozo PJ, Stern JM, Jaffe W, Natale, R, Kovell,R, Bergey MR, Lee DI “Pelvic anatomy on preoperative magnetic resonance imaging can predict early continence after robot-assisted radical prostatectomy”, J endourology. 2011. 25(1), 51-55

33. Patel VR, Coelho RF, Rocco B, Orvieto M, Sivaraman A, Palmer KJ, Kameh D, Santoro L, Coughlin GD, Liss M, Jeong W, Malcolm J, Stern JM, Sharma S, Zorn KC, Shikanov S, Shalhav AL, Zagaja GP, Ahlering TE, Rha KH, Albala DM, Fabrizio MD, Lee DI, Chauhan S “Positive Surgical Margins After Robotic Assisted Radical Prostatectomy: A Multi-Institutional Study” J Urol. 2011 Aug;186(2):511-6. Epub 2011 Jun 15

34. Joshua M Stern, Saurabh Sharma, Noemi Alice Spinazzi, Pierre Mendoza, Mary Walicki, Rachel Hastings, Kelly Monahan, Baber Sheikh, Alexei Wedmid and David I. Lee. “Surgeon perception is not a good predictor of peri-operative outcomes in robot-assisted radical prostatectomy” Journal of Robotic Surgery, Online First™, 13 August 2011.

35. Chuback B, Stern JM. “An Unusual Presentation of Colon Perforation Following Percutaneous Nephrolithotomy”. Can Urol Assoc J. 2014 Nov;8(11-12):E8626

36. Keehn A, Ghavamian R, Stern JM. “The Relationship Between Visceral Obesity and the Clinicopathologic Features of Patients with Small Renal Masses”. J endourology. 2015 Mar;29(3):372-6

37. Fram E, Divito JD, Stern JM, “The Visceral Fat Compartment is Independently Associated with Changes in Urine Constituent Excretion in a Stone Forming Population”, Uroltihiasis, 2015 Jun;43(3):213-20

38. Stern JM, Schwartz J. “Initial evaluation of the safety of nanoshell-directed phoththermal therapy in the treatment of prostate disease”, International Journal of Toxicology, in press Aug, 2015

39. Fram E, Moazami S, Stern JM. “The Effect of Disease Severity on 24-Hour Urine Parameters in Kidney Stone Patients with Type II Diabetes”. Urology. 2016 Jan;87:52-9

40. Stern JM, Moazami S, Burk R et al. ““Evidence for a Distinct Gut Microbiome in Kidney Stone Formers Compared to Non-stone Formers.” Urolithiasis, accepted April, 2016.

Invited Book Chapters:

1. Stern JM, Lee DI. “Radical Prostatectomy: Transperitoneal Approach”. Atlas of Robotic Urologic Surgery, 2011.

2. Watts K, Stern JM. “Nanotechnology: An evolution in tissue preservation and focal targeted oncologic therapy”. Management of Urologic Cancer: Focal Therapy and Tissue Preservation, 2014 Wiley Publishing.

3. Moazami S, Stern JM “Advanced endoscpic evaluation and treatment for urotheilial carcinoma of the ureter and kidney”. Urothelial Malignancies of the Upper Urinary Tract: A Textbook of Step by Step Management In Press, 2015, Springer Publishing.

Research Presentations:

• “A gut microbiome signature in kidney stone formers”, World Congress of Endourology, London, 2015

• “The Visceral Fat Compartment is Independently Associated with Changes in Urine electrolyte excretion in a stone forming population” American Urologic Association Annual Meeting, Orlando, 2014.

• “Assessing Difficulty of Ureteroscopic Stone Extraction Using Preoperative CT Imaging” World Congress Endourology, New Orleans, 2013

• “Visceral Fat as a Marker in Kidney and Tumor Physiology”, World Congress Endourology, New Orleans, 2013

• “Laser Activated Nanoshell Ablation of Prostate Cancer: A pilot study in Humans”, American Urologic Association Annual Meeting, San Diego 2013

• “Robotic technique and Technology Highlights from the 2010 AUA”, New England Section AUA annual Meeting, Providence RI 2010

• “Urethral Length as Measured on MRI is Associated with Time to Urinary Continence” American Urologic Association Annual Meeting, Chicago, Il 2009.

• “Posterior Reconstruction after Robotic ProstatectomY: Implications for Recovery of Continence.: Global Robotics Meeting, Orlando, 2009

• “PSA Less than 2.6: Pathologic Outcomes Reveal Significant Disease” World Congress of Endourology, Shanghai, China 2008.

• “Absence Of Viable Renal Carcinoma in Biopsies Performed Greater than 1 Year Following Radiofrequency Ablation Confirms Reliability of Axial Imaging” American Urologic Association Annual Meeting, Orlando, FL 2008

• “Pre-clinical Study of Nanotechnology and Urology”, Society of Basic Urologic Research Annual Meeting, Orlando, FL 2008

• “Laser assisted nanoshell ablation of the prostate” Texas Nanotechnology Forum. Dallas, TX 2007

• “The evolution of nantechnology from the bench to the OR” Texas Nanotechnology Forum. Dallas, TX 2006.

• “The efficacy of Laser activated Gold Nanoshells to ablate prostate cancer cells in vitro” World Congress of Endourology, Cleveland, OH 2006

• “Kidney Tumor Radiofrequency Ablation: Experience in ASA I and II patients”

American Urologic Association annual meeting, Atlanta, GA 2006.

• “Intermediate Follow-Up Comparison Between Partial Nephrectomy And Radio Frequency Ablation In T1a Renal Tumors” American Urologic Association annual meeting, Atlanta, GA 2006

• “In Vitro Analysis of a Nanocrystalline Silver Coated Polypropylene Mesh”, Northeastern/New England Section AUA, Bermuda, 2005

• “Nanotechnology: applications within medicine and surgery.” Harvard Business School Cyberposium, Boston MA, 2004.

• “Androgen Application Stimulates Angiogensis in Human Foreskin Grafts” American Academy of Pediatrics National Conference, New Orleans, LA 2003

• “Effect of UUO on D1AR expression reveals a link between Dopamine, Transforming Growth Factor-β and Nitric Oxide” American Urologic Association annual meeting, Chicago, IL 2003.

• “Dopamine-1A Receptor (D1AR) Is Decreased in Unilateral Ureteral Obstruction (UUO) in Rats” American Society of Nephrology annual meeting, Philadelphia, PA 2002

• “Dr. Patch Adams: Symposium on Humor and Medicine” Weill Medical College, NY, NY 2001

• “TGF-β mediated expression of p53 and bcl-2 in UUO” American Urologic Association annual meeting, Atlanta, GA, 2000

• “Antibody to TGF-β modulates apoptosis, p53 and bcl-2 expression in Unilateral Ureteral Obststruction” New York City Valentine Urologic Residency Competition, New York, NY 2000

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download